Logo image of EYX.DE

EXOR NV (EYX.DE) Stock Fundamental Analysis

Europe - FRA:EYX - NL0012059018 - Common Stock

76.2 EUR
+0.65 (+0.86%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

4

EYX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Financial Services industry. While EYX has a great health rating, there are worries on its profitability. EYX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

EYX had negative earnings in the past year.
In the past year EYX had a positive cash flow from operations.
EYX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years EYX had a positive operating cash flow.
EYX.DE Yearly Net Income VS EBIT VS OCF VS FCFEYX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

With a Return On Assets value of -1.62%, EYX is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
EYX's Return On Equity of -1.78% is on the low side compared to the rest of the industry. EYX is outperformed by 70.00% of its industry peers.
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EYX.DE Yearly ROA, ROE, ROICEYX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

In the last couple of years the Profit Margin of EYX has grown nicely.
In the last couple of years the Operating Margin of EYX has grown nicely.
EYX has a Gross Margin of -5096.69%. This is in the lower half of the industry: EYX underperforms 66.00% of its industry peers.
In the last couple of years the Gross Margin of EYX has grown nicely.
The Profit Margin and Operating Margin are not available for EYX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -5096.69%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EYX.DE Yearly Profit, Operating, Gross MarginsEYX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

8

2. Health

2.1 Basic Checks

EYX does not have a ROIC to compare to the WACC, probably because it is not profitable.
EYX has less shares outstanding than it did 1 year ago.
EYX has less shares outstanding than it did 5 years ago.
EYX has a better debt/assets ratio than last year.
EYX.DE Yearly Shares OutstandingEYX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EYX.DE Yearly Total Debt VS Total AssetsEYX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

EYX has an Altman-Z score of 3.91. This indicates that EYX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.91, EYX is doing good in the industry, outperforming 78.00% of the companies in the same industry.
EYX has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
The Debt to FCF ratio of EYX (1.25) is better than 78.00% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that EYX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.08, EYX is doing good in the industry, outperforming 72.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Altman-Z 3.91
ROIC/WACCN/A
WACC4.65%
EYX.DE Yearly LT Debt VS Equity VS FCFEYX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

EYX has a Current Ratio of 2.21. This indicates that EYX is financially healthy and has no problem in meeting its short term obligations.
EYX's Current ratio of 2.21 is fine compared to the rest of the industry. EYX outperforms 72.00% of its industry peers.
EYX has a Quick Ratio of 2.21. This indicates that EYX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of EYX (2.21) is better than 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
EYX.DE Yearly Current Assets VS Current LiabilitesEYX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

0

3. Growth

3.1 Past

The earnings per share for EYX have decreased strongly by -104.11% in the last year.
EYX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.47% yearly.
EYX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.78%.
Measured over the past years, EYX shows a very negative growth in Revenue. The Revenue has been decreasing by -36.03% on average per year.
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%

3.2 Future

The Earnings Per Share is expected to decrease by -51.47% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-121.49%
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EYX.DE Yearly Revenue VS EstimatesEYX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B
EYX.DE Yearly EPS VS EstimatesEYX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

EYX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 23.39, EYX is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as EYX.
When comparing the Price/Forward Earnings ratio of EYX to the average of the S&P500 Index (23.18), we can say EYX is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 23.39
EYX.DE Price Earnings VS Forward Price EarningsEYX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, EYX is valued cheaply inside the industry as 82.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.63
EV/EBITDA N/A
EYX.DE Per share dataEYX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

EYX's earnings are expected to decrease with -51.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.64%, EYX is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.62, EYX has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, EYX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

The dividend of EYX decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EYX.DE Yearly Dividends per shareEYX.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

EYX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The Dividend Rate of EYX has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-14.35%
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%
EYX.DE Yearly Income VS Free CF VS DividendEYX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

EXOR NV

FRA:EYX (10/20/2025, 7:00:00 PM)

76.2

+0.65 (+0.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-17 2025-09-17
Earnings (Next)03-24 2026-03-24
Inst Owners29.18%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.83B
Analysts85
Price Target120.09 (57.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP-14.35%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)0.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-208.7%
EPS NY rev (3m)-194.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.39
P/S N/A
P/FCF 5.63
P/OCF 5.63
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-3.12
EYN/A
EPS(NY)3.26
Fwd EY4.27%
FCF(TTM)13.53
FCFY17.76%
OCF(TTM)13.53
OCFY17.76%
SpS-1.45
BVpS174.97
TBVpS174.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -5096.69%
FCFM -931.13%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score5
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z 3.91
F-Score5
WACC4.65%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
EPS Next Y-121.49%
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-102.73%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.71%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-52.81%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%